Detail Career Comeback   Oleh:  Salmon, Andrew Jenis: Article from Bulletin/Magazine Dalam koleksi: Forbes Asia vol. 5 no. 8 (May 2009), page 30-32. Topik: Korean Entrepreneur; Drug Industry; Biopharmaceutical Company; Biotech Company Ketersediaan Perpustakaan Pusat (Semanggi) Nomor Panggil: FF5.1 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada     Lihat Detail Induk Isi artikel Out of work, Seo Jung-Jin decided to become an entrepreneur. With Korean drugmaker Celltrion, it looks like he picked the right industry. Today, at 52, he is running Celltrion, a biopharmaceutical company that he helped found and build into a stock market star. Its shares on the Kosdaq over-the-counter market have soared 600% since early last year, to a recent price of $12, boosting the startups's market capitalization to $1.3 billion. That's made him wealthy. Forbes Asia estimates he's worth at least $250 million, which gets him close to earning a place on our list. Opini Anda Klik untuk menuliskan opini Anda tentang koleksi ini! Kembali

Copyright © 2006, 2007 Unika Atma Jaya, all rights reserved